The effect of rehabilitation of northern elephant seals (Mirounga angustirostris) on antimicrobial resistance of commensal Escherichia coli

Veterinary Microbiology

Volumn 133, Issue 3, 2009, Pages 264-271

  Stoddard, Robyn A ^a,b   Atwill, E Rob ^a   Conrad, Patricia A ^a   Byrne, Barbara A ^a,c   Jang, Spencer ^c   Lawrence, Judy ^b   McCowan, Brenda ^a   Gulland, Frances M D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b THE MARINE MAMMAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antimicrobial drug resistance; Escherichia coli; Mirounga angustirostris; Northern elephant seal

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFAZOLIN; CEFTIOFUR; CEFTIZOXIME; CHLORAMPHENICOL; COTRIMAZINE; COTRIMOXAZOLE; DOXYCYCLINE; ENROFLOXACIN; GENTAMICIN; TETRACYCLINE; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BINOMIAL DISTRIBUTION; BROTH DILUTION; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FISHER EXACT TEST; LEPTOSPIROSIS; LOGISTIC REGRESSION ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHILIA; NONHUMAN; PREVALENCE; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEAL; SEPTICEMIA; SKIN INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; MICROBIAL SENSITIVITY TESTS; SEALS, EARLESS;

ANIMALIA; ESCHERICHIA COLI; MIROUNGA ANGUSTIROSTRIS;

EID: 57649129786     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2008.07.022     Document Type: Article

References (24)

1. Berge A.C., Atwill E.R., and Sischo W.M. Animal and farm influences on the dynamics of antibiotic resistance in faecal Escherichia coli in young dairy calves. Prev. Vet. Med. 69 (2005) 25-38
2. Bopp C.A., Brenner F.W., Fields P.I., Wells J.G., and Strockbine N.A. Escherichia, Shigella, and Salmonella. In: Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. (Eds). Manual of Clinical Microbiology. 8th ed. (2003), ASM Press, Washington, DC 654-671
3. Colegrove K.M., Greig D.J., and Gulland F.M.D. Causes of live strandings of northern elephant seals (Mirounga angustirostris) and pacific harbor seals (Phoca vitulina) along the Central California Coast, 1992-2001. Aquat. Mammal 31 (2005) 1-10
4. Cowan D.F., House C., and House J.A. Public health. In: Dierauf L.A., and Gulland F.M.D. (Eds). CRC Handbook of Marine Mammal Medicine. 2nd ed. (2001), CRC Press, Boca Raton 767-778
5. Cunha B.A. Antibiotic resistance. Med. Clin. North Am. 84 (2000) 1407-1429
6. Dzidic S., and Bedekovic V. Horizontal gene transfer-emerging multidrug resistance in hospital bacteria. Acta Pharmacol. Sin. 24 (2003) 519-526
7. Farley, C., Raftery, A.E., 2000. Model-based clustering, discriminate analysis, and density estimation, Technical Report No. 380. University of Washington, Seattle.
8. Farley, C., Raftery, A.E., 2002. MCLUST: Software for model-based clustering, density estimation and discriminate analysis, Report No. 415. University of Washington.
9. Gerber J.A., Roletto J., Morgan L.E., Smith D.M., and Gage L.J. Findings in pinnipeds stranded along the central and northern California coast, 1984-1990. J. Wildl. Dis. 29' (1993) 423-433
10. Gulland F.M.D., Haulena M., and Dierauf L.A. Seals and sea lions. In: Dierauf L.A., and Gulland F.M.D. (Eds). CRC Handbook of Marine Mammal Medicine. 2nd ed. (2001), CRC Press, Boca Raton 907-926
11. Hosein I.K., Hill D.W., Jenkins L.E., and Magee J.T. Clinical significance of the emergence of bacterial resistance in the hospital environment. Symp. Ser. Soc. Appl. Microbiol. 31 (2002) 90S-97S
12. Johnson S.P., Nolan S., and Gulland F.M. Antimicrobial susceptibility of bacteria isolated from pinnipeds stranded in central and northern California. J. Zoo Wildl. Med. 29 (1998) 288-294
13. McEwen S.A., and Fedorka-Cray P.J. Antimicrobial use and resistance in animals. Clin. Infect. Dis. 4 Suppl. (2002) S93-S106
14. National Committee for Clinical Laboratory Standards, 2002a. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, Approved Standards, NCCLS Document M31-A2. NCCLS, Wayne, PA.
15. National Committee for Clinical Laboratory Standards, 2002b. Performance standards for antimicrobial susceptibility testing: twelfth informational supplement, NCCLS Document M100-S12. NCCLS, Wayne, PA.
16. National Marine Fisheries Service, 2000. Northern Elephant Seal (Mirounga angustirostris): California Breeding Stock, National Oceanic and Atmospheric Administration, Silver Springs, MD, pp. 1-5. [Online.] http://www.nmfs.noaa.gov/pr/PR2/Stock_Assessment_Program/Pinnipeds/North ern_Elephant_Seal_(CA_Breeding)/PO00northernelephantseal_CAbreeding.pdf.
17. National Marine Fisheries Service, 1972. Marine Mammal Protection Act (MMPA) of 1972, 16 U.S.C.1361-1407. National Oceanic and Atmospheric Administration, Silver Springs, MD, pp. 1-119. [Online.] http://www.nmfs.noaa.gov/pr/laws/MMPA/mmpatext/mmpaall.pdf. http://www.nmfs.noaa.gov/pr/laws/MMPA/mmpatext/mmpaall.pdf.
18. In: Prescott J.F., Baggot J.D., and Walkerm R.D. (Eds). Antimicrobial Therapy in Veterinary Medicine. 3rd ed. (2000), Iowa State Press, Ames, Iowa pp. 105-176, 191-228, 275-338
19. Russell A.D. Antibiotic and biocide resistance in bacteria: comments and conclusions. J. Appl. Microbiol. 92 Suppl. (2002) 171S-173S
20. Sanchez S., McCrackin-Stevenson M.A., Hudson C.R., Maier M., Buffington T., Dam Q., and Maurer J.J. Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs. J. Clin. Microbiol. 40 (2002) 3586-3595
21. Smith A.W., Vedros N.A., Akers T.G., and Gilmartin W.G. Hazards of disease transfer from marine mammals to land mammals: review and recent findings. J. Am. Vet. Med. Assoc. 173 (1978) 1131-1133
22. Stoddard R.A., Atwill E.R., Gulland F.M.D., Miller M.A., Dabritz H.A., Paradies D.M., Worcester K.R., Jang S., Lawrence J., Byrne B.A., and Conrad P.A. Risk factors for infection with pathogenic and antimicrobial-resistant fecal bacteria in northern elephant seals in California. Public Health Rep. 123 (2008) 360-370
23. Trott D.J., Filippich L.J., Bensink J.C., Downs M.T., McKenzie S.E., Townsend K.M., Moss S.M., and Chin J.J. Canine model for investigating the impact of oral enrofloxacin on commensal coliforms and colonization with multidrug-resistant Escherichia coli. J. Med. Microbiol. 53 (2004) 439-443
24. Wiuff C., Lykkesfeldt J., Svendsen O., and Aarestrup F.M. The effects of oral and intramuscular administration and dose escalation of enrofloxacin on the selection of quinolone resistance among Salmonella and coliforms in pigs. Res. Vet. Sci. 75 (2003) 185-193